CTI BIOPHARMA CORP Quarterly Debt-to-equity in % from Q1 2012 to Q3 2022

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Cti Biopharma Corp quarterly Debt-to-equity history and growth rate from Q1 2012 to Q3 2022.
  • Cti Biopharma Corp Debt-to-equity for the quarter ending September 30, 2022 was -1.1K %, a 1734% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2022 -1.1K -1.17K -1734% Sep 30, 2022
Q2 2022 4.55K +4.51K +11892% Jun 30, 2022
Q1 2022 400 +359 +872% Mar 31, 2022
Q4 2021 124 +80.2 +181% Dec 31, 2021
Q3 2021 67.2 +11.9 +21.4% Sep 30, 2021
Q2 2021 37.9 -34.8 -47.9% Jun 30, 2021
Q1 2021 41.2 -50.3 -55% Mar 31, 2021
Q4 2020 44.2 -39.7 -47.3% Dec 31, 2020
Q3 2020 55.4 -17.1 -23.6% Sep 30, 2020
Q2 2020 72.7 +6.19 +9.31% Jun 30, 2020
Q1 2020 91.5 +29.8 +48.4% Mar 31, 2020
Q4 2019 84 +26.9 +47.3% Dec 31, 2019
Q3 2019 72.5 +5.55 +8.29% Sep 30, 2019
Q2 2019 66.5 -7.26 -9.84% Jun 30, 2019
Q1 2019 61.7 -26.7 -30.2% Mar 31, 2019
Q4 2018 57 -129 -69.4% Dec 31, 2018
Q3 2018 66.9 -157 -70.1% Sep 30, 2018
Q2 2018 73.8 -239 -76.4% Jun 30, 2018
Q1 2018 88.4 -256 -74.4% Mar 31, 2018
Q4 2017 186 -1.83 -0.97% Dec 31, 2017
Q3 2017 224 +54.7 +32.3% Sep 30, 2017
Q2 2017 313 +69.7 +28.7% Jun 30, 2017
Q1 2017 345 -106 -23.5% Mar 31, 2017
Q4 2016 188 -751 -80% Dec 31, 2016
Q3 2016 169 -983 -85.3% Sep 30, 2016
Q2 2016 243 -109 -31% Jun 30, 2016
Q1 2016 450 +238 +112% Mar 31, 2016
Q4 2015 938 +757 +417% Dec 31, 2015
Q3 2015 1.15K +992 +618% Sep 30, 2015
Q2 2015 352 +174 +97.2% Jun 30, 2015
Q1 2015 212 +21.5 +11.3% Mar 31, 2015
Q4 2014 182 -30.2 -14.2% Dec 31, 2014
Q3 2014 160 -73 -31.3% Sep 30, 2014
Q2 2014 179 -113 -38.7% Jun 30, 2014
Q1 2014 191 -270 -58.6% Mar 31, 2014
Q4 2013 212 -272 -56.2% Dec 31, 2013
Q3 2013 234 -367 -61.1% Sep 30, 2013
Q2 2013 292 +33 +12.8% Jun 30, 2013
Q1 2013 461 +276 +149% Mar 31, 2013
Q4 2012 484 Dec 31, 2012
Q3 2012 600 Sep 30, 2012
Q2 2012 258 Jun 30, 2012
Q1 2012 185 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.